Santen Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3336000009
JPY
2,045.00
41 (2.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
2,91,624.00
3,00,004.00
3,01,965.00
2,79,037.00
2,66,257.00
2,49,605.00
2,41,555.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,91,624.00
3,00,004.00
3,01,965.00
2,79,037.00
2,66,257.00
2,49,605.00
2,41,555.00
Raw Material Cost
1,36,507.00
1,36,795.00
1,38,089.00
1,22,468.00
1,19,405.00
1,08,871.00
1,06,852.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
63,444.00
57,319.00
63,870.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1,391.00
1,083.00
831.00
486.00
250.00
172.00
750.00
Selling and Distribution Expenses
84,538.00
83,511.00
87,270.00
96,257.00
84,499.00
79,554.00
71,898.00
Other Expenses
-3,947.10
-3,493.50
-3,999.80
2,781.10
2,612.70
2,394.00
2,193.00
Total Expenditure (Excl Depreciation)
2,46,409.00
2,43,773.00
2,50,062.00
2,47,022.00
2,30,281.00
2,12,537.00
2,01,430.00
Operating Profit (PBDIT) excl Other Income
45215
56231
51903
32015
35976
37068
40125
Other Income
7,490.00
3,159.00
2,094.00
107.00
684.00
15,805.00
-46.00
Operating Profit (PBDIT)
71,063.00
77,338.00
72,175.00
49,371.00
53,715.00
70,795.00
56,652.00
Interest
1,391.00
1,083.00
831.00
486.00
250.00
172.00
750.00
Exceptional Items
-3,872.00
-10,140.00
-15,718.00
-35,073.00
809.00
-40,788.00
-7,237.00
Gross Profit (PBDT)
1,55,117.00
1,63,209.00
1,63,876.00
1,56,569.00
1,46,852.00
1,40,734.00
1,34,703.00
Depreciation
18,358.00
17,948.00
18,178.00
17,249.00
17,055.00
17,922.00
16,573.00
Profit Before Tax
47,442.00
48,166.00
37,449.00
-3,437.00
37,220.00
12,046.00
32,091.00
Tax
9,881.00
11,628.00
3,171.00
9,184.00
8,427.00
2,562.00
10,377.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
37,360.00
36,247.00
26,635.00
-14,955.00
27,224.00
9,315.00
23,616.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
37,360.00
36,247.00
26,635.00
-14,955.00
27,224.00
9,315.00
23,616.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
192.00
-403.00
60.00
-35.00
-29.00
-185.00
-1,904.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
37,552.00
35,844.00
26,695.00
-14,990.00
27,195.00
9,130.00
21,712.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
2,96,989.00
2,86,242.00
3,06,054.00
2,93,979.00
3,37,488.00
3,10,181.00
3,02,865.00
Earnings per share (EPS)
113.8
103.68
72.37
-38.6
67.97
23.25
59.01
Diluted Earnings per share
113.8
103.68
72.37
-38.6
67.97
23.25
59.01
Operating Profit Margin (Excl OI)
15.5%
18.74%
17.19%
11.47%
13.51%
14.85%
16.61%
Gross Profit Margin
22.56%
22.04%
18.42%
4.95%
20.38%
12.01%
20.15%
PAT Margin
12.81%
12.08%
8.82%
-5.36%
10.22%
3.73%
9.78%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -2.79% vs -0.65% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 4.77% vs 34.27% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -14.30% vs 5.85% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 28.44% vs 30.32% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has fallen from Mar 2025

Compare Annual Results Of Santen Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
2,91,624.00
1,65,742.00
1,25,882.00
75.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,91,624.00
1,65,742.00
1,25,882.00
75.95%
Raw Material Cost
1,36,507.00
86,306.00
50,201.00
58.17%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
63,444.00
0.00
63,444.00
Power Cost
0
0
0.00
Manufacturing Expenses
1,391.00
28.00
1,363.00
4,867.86%
Selling and Distribution Expenses
84,538.00
54,205.00
30,333.00
55.96%
Other Expenses
-3,947.10
909.40
-4,856.50
-534.03%
Total Expenditure (Excl Depreciation)
2,46,409.00
1,49,633.00
96,776.00
64.68%
Operating Profit (PBDIT) excl Other Income
45,215.00
16,109.00
29,106.00
180.68%
Other Income
7,490.00
7,338.00
152.00
2.07%
Operating Profit (PBDIT)
71,063.00
30,928.00
40,135.00
129.77%
Interest
1,391.00
28.00
1,363.00
4,867.86%
Exceptional Items
-3,872.00
-18,411.00
14,539.00
78.97%
Gross Profit (PBDT)
1,55,117.00
79,436.00
75,681.00
95.27%
Depreciation
18,358.00
8,745.00
9,613.00
109.93%
Profit Before Tax
47,442.00
3,744.00
43,698.00
1,167.15%
Tax
9,881.00
83.00
9,798.00
11,804.82%
Provisions and contingencies
0
0
0.00
Profit After Tax
37,360.00
3,656.00
33,704.00
921.88%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
37,360.00
3,656.00
33,704.00
921.88%
Share in Profit of Associates
0
0
0.00
Minority Interest
192.00
4.00
188.00
4,700.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
37,552.00
3,660.00
33,892.00
926.01%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
2,96,989.00
2,10,999.00
85,990.00
40.75%
Earnings per share (EPS)
113.80
49.18
64.62
131.39%
Diluted Earnings per share
113.80
49.18
64.62
131.39%
Operating Profit Margin (Excl OI)
15.50%
8.96%
0.00
6.54%
Gross Profit Margin
22.56%
7.54%
0.00
15.02%
PAT Margin
12.81%
2.21%
0.00
10.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 29,162.40 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -2.79% vs -0.65% in Mar 2025

Annual - Consolidate Net Profit
Consolidate Net Profit 3,755.20 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 4.77% vs 34.27% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6,357.30 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is -14.30% vs 5.85% in Mar 2025

Annual - Interest
Interest 139.10 Million
in Mar 2026

Figures in Million
stock-summary

YoY Growth in year ended Mar 2026 is 28.44% vs 30.32% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.50%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has fallen from Mar 2025